PTEN and prostate carcinoma: Consistent bone metastasis was reported in mice with prostate cancer caused by deletion of PTEN/P53 and the loss and subsequent re-activation of Telomerase [25]; however, subsequent pathological analysis suggested direct bone invasion from large primary tumors rather than bona fide bone metastasis [26].